Business

Psychedelic Business Spotlight – February 4

Why Mindset Pharma’s Deal with Big Pharma Is a Big Deal for Psychedelics

The partnership with global pharmaceutical company Otsuka positions the psychedelic medicine company as a leader in the industry....

Psychedelic Business Spotlight — January 28

This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one of the biggest gets bigger....

MindMed gets FANTASTIC News from the FDA, Causing its Stock to Skyrocket (MNMD/MMED) | Project Lucy

Follow us on Twitter: @Psy_Invest @psy_holy @PsycSpotlight Follow us on Instagram: @thepsychedelicinvestor @psycspotlight To learn more about the emerging psychedelic...

Rick Doblin Interview: Psychedelics and the Soviets, A “Driver’s License” to take Drugs, Curing PTSD

Donate to MAPS: https://maps.org/about-maps/our-team/ Follow us on Twitter: @Psy_Invest @psy_holy @PsycSpotlight Follow us on Instagram: @thepsychedelicinvestor @psycspotlight To learn more...

Psychedelic Business Spotlight – January 21

Catch up on some of the biggest psychedelic business developments that unfolded in the last week....

Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary Technology

The technology may be more broadly used in the future for neuroscientific or physiological studies of brain activity during psychedelic...

Can Next Generation Psychedelics Treat Mental Illness? | Mindset Pharma | DMT, 5-MEO-DMT

In today’s episode of the Psychedelic Spotlight Podcast, The Psychedelic Investor sits down with James Lanthier, CEO of Mindset Pharma...

Psychedelic Business Spotlight — January 14

This week in psychedelic business news: Another psychedelics company starts trading on OTCQB; another ketamine trial delivers; and another patent...

Can DMT Treat Depression?

Welcome to the Psychedelic Spotlight podcast. In this episode, the Psychedelic Investor sits down with Dr. Carol Routledge, Chief Scientific...